Please find attached intimation regarding rescheduling of Earnings Conference Call for Q2 & H1 FY27

October 22, 2026 BSE Limited National Stock Exchange of India Limited P J Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543904 Symbol: MANKIND Dear Sir/ Madam, Sub.: Rescheduling of Earnings Conference Call for Q2 & H1 FY27 Ref.: Regulation 30 & 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) This is in continuation of our earlier intimation dated October 12, 2026, regarding the schedule of the Earnings Conference Call for Q2 & H1 FY27. In this regard, we wish to inform you that, due to certain unavoidable circumstances, the Earnings Conference Call, which was originally scheduled to be held on Monday, October 26, 2026, at 06:00 P.M. (IST), will now be held at 05:00 P.M. (IST) on the same date. All other details of the Earnings Conference Call, as communicated earlier, shall remain unchanged. Please find the link for the Earnings Conference Call: Q2 & H1 FY27 Earnings Conference Call You are requested to take the above information on record and disseminate the same on your respective websites. Above information is also available on the website of the Company at www.mankindpharma.com. Kindly take the same on record. Thanking you Yours Faithfully, For Mankind Pharma Limited Hitesh Kumar Jain Company Secretary & Compliance Officer